Biological medicines for asthma

RX_ASTMA_BIOL

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC R03DX05|R03DX08|R03DX09|R03DX10|D11AH05

56

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

46

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

46

diagram downward connector

Include endpoints None

46

diagram downward connector
RX_ASTMA_BIOL

Extra metadata

First used in FinnGen datafreeze DF5

Summary Statistics

Key figures

All Female Male
Number of individuals 46 32 14
Unadjusted prevalence (%) 0.01 0.02 0.01
Mean age at first event (years) 49.62 49.83 49.15

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: RX_ASTMA_BIOL – Biological medicines for asthma
GWS hits:

Survival analyses between endpoints

Plot

before Biological medicines for asthma
after Biological medicines for asthma

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Biological medicines for asthma